09:43:24 Europe / Stockholm
Svenska | English

Vimian Group

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-13 Bokslutskommuniké 2024
2024-10-24 Kvartalsrapport 2024-Q3
2024-08-15 Kvartalsrapport 2024-Q2
2024-05-23 X-dag ordinarie utdelning VIMIAN 0.00 SEK
2024-05-22 Årsstämma 2024
2024-05-02 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-08 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-06-02 Årsstämma 2023
2023-06-02 X-dag ordinarie utdelning VIMIAN 0.00 SEK
2023-05-04 Kvartalsrapport 2023-Q1
2023-03-24 Extra Bolagsstämma 2023
2023-03-08 Bokslutskommuniké 2022
2022-11-16 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-03 X-dag ordinarie utdelning VIMIAN 0.00 SEK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-09 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Vimian Group är en koncern verksam inom djurhälsa. Bolaget levererar via sina dotterbolag läkemedel och tekniska lösningar till veterinärer, laboratorier och husdjursägare. Produkterna inkluderar exempelvis läkemedel med tillhörande klinisk forskning samt digitala plattformar för veterinärkliniker. Bolaget är verksamma på en global nivå med huvudkontor i Stockholm.
Fidelio issues call options to Vimian’s Chairman of the Board Magnus Welander
2024-06-27 15:30:00

Vimian Group AB (publ) has been informed that the Company’s largest shareholder Fidelio Vet Holding AB (“Fidelio”) has undertaken to issue 100,000 call options in Vimian to Magnus Welander, Chairman of the Board in Vimian Group AB (publ).

The call options are being issued on market terms and are exercisable into 100,000 shares in Vimian after five years, in three tranches with an exercise price corresponding to SEK 33.16 subject to an annual step-up in exercise price of 5, 10 and 15 percent, respectively, starting on 27 June 2024.

The call options will not dilute the holdings of other shareholders and do not entail any costs for Vimian.

Today, Fidelio owns approximately 297,128,581 shares in Vimian, corresponding to 57% of the shares in Vimian Group AB (publ). Magnus Welander currently owns 73,630 shares in Vimian Group AB (publ).

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 736 26 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.

Attachments

Fidelio issues call options to Vimian’s Chairman of the Board Magnus Welander

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden